Fragment 176-191 Reconstitution: Step-by-Step Laboratory Guide
Fragment 176-191 Reconstitution: Step-by-Step Laboratory Guide
Fragment 176-191 represents a modified segment of the growth hormone molecule, specifically encompassing amino acids 176-191 of the human growth hormone sequence. This peptide fragment has garnered significant attention in metabolic research laboratories for its unique properties in lipid metabolism studies. Research institutions utilize this compound extensively in cellular assays investigating adipocyte function, lipolytic pathways, and energy expenditure mechanisms in controlled laboratory environments.
Materials Required for Reconstitution
Fragment 176-191 lyophilised vial (5mg from Element SARMs)
Bacteriostatic water for injection or sterile water for injection
Sterile disposable syringes (1mL and 3mL capacity)
Sterile needles (25G or 27G, 1-inch length)
Alcohol prep pads (70% isopropyl alcohol)
Laboratory-grade vortex mixer
Refrigerated centrifuge (optional)
Sterile amber glass vials for aliquoting
Laboratory labels and permanent marker
Laminar flow hood or biosafety cabinet
Pre-Reconstitution Preparation
Establish optimal laboratory conditions by ensuring all work surfaces undergo thorough decontamination using appropriate disinfectants. Verify that the laminar flow hood operates correctly with adequate airflow patterns. Allow the lyophilised Fragment 176-191 vial to equilibrate to room temperature for approximately 15-20 minutes before commencing reconstitution procedures. This temperature equilibration prevents thermal shock and ensures consistent solubility characteristics.
Inspect the lyophilised powder for uniform appearance and absence of discoloration or clumping. The powder should exhibit a white to off-white appearance with fine, uniform texture. Document any observations regarding the physical characteristics of the starting material in laboratory records.
Step-by-Step Reconstitution Protocol
Step 1: Position the Fragment 176-191 vial securely within the laminar flow hood and remove the protective cap. Clean the rubber stopper thoroughly using alcohol prep pads, allowing complete evaporation of residual alcohol before proceeding.
Step 2: Using aseptic technique, draw the predetermined volume of bacteriostatic water into a sterile syringe. Calculate the required volume based on desired final concentration using the formula: Volume (mL) = Mass (mg) ÷ Desired Concentration (mg/mL).
Step 3: Insert the needle through the rubber stopper at a slight angle, ensuring the bevel faces downward. Direct the solvent flow toward the vial wall rather than directly onto the lyophilised cake to minimize foaming and preserve peptide integrity.
Step 4: Inject the solvent slowly and steadily, maintaining gentle pressure to create a smooth flow. Observe the reconstitution process, noting the dissolution pattern and ensuring no excessive agitation occurs during solvent addition.
Step 5: After complete solvent addition, gently swirl the vial in circular motions to facilitate dissolution. Avoid vigorous shaking or vortexing, which may cause protein denaturation or excessive foam formation.
Step 6: Allow the vial to stand undisturbed for 2-3 minutes, permitting complete hydration of the peptide. If necessary, apply gentle finger-tapping to the vial sides to encourage dissolution of any remaining particles.
Step 7: Visually inspect the reconstituted solution for complete dissolution and clarity. The final solution should appear clear and colorless without visible particulates or precipitates.
Concentration Options
1.0 mL
5.0 mg/mL
High-concentration stock solutions
2.0 mL
2.5 mg/mL
Standard working concentrations
5.0 mL
1.0 mg/mL
Dilute assay preparations
Storage Conditions
Store the reconstituted Fragment 176-191 solution under refrigerated conditions at 2-8°C for short-term stability up to 4 weeks. For extended storage periods, aliquot the solution into smaller volumes using sterile amber vials to minimize freeze-thaw cycles. Long-term storage at -20°C maintains peptide stability for up to 6 months when properly sealed and protected from light exposure.
Label all storage containers with reconstitution date, concentration, and storage temperature requirements. Implement a first-in, first-out inventory system to ensure optimal utilization of research materials within their stability timeframes.
Research Application Notes
Element SARMs Fragment 176-191 demonstrates optimal performance in cell culture assays when diluted to working concentrations immediately before experimental use. Research laboratories commonly employ this peptide in studies examining adipose tissue metabolism, cellular energy expenditure, and lipolytic enzyme activity. The reconstituted material maintains consistent biological activity when handled according to these established protocols, ensuring reproducible experimental outcomes across multiple research sessions.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Hexarelin
TB-500
Epithalon
Ipamorelin
Tirzepatide
CJC-1295 DAC
PT-141
Semaglutide
Selank
BPC-157
Sermorelin
Melanotan 2
IGF LR3
Tesamorelin
AICAR
IGF-DES
GHRP 2
Albuterol
Tamoxifen
Letrozole
Clomiphene
Tadalafil
Clenbuterol
Anastrozole
Finasteride
Exemestane
Sildenafil
Yohimbine
Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows
Already a customer? Sign In
Create Account
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Sarms
Stacks
Research Liquids
Albuterol 5MG/ML | 30ML with dropper
Anastrozole 1.5MG/ML | 30ML with dropper
Clomiphene 50MG/ML | 30ML with dropper
Finasteride 5MG/ML | 30ML with dropper
Letrozole 3.5 MG/ML | 30ML with dropper
LiquiCia 30MG/ML | 30ML with dropper
LiquiCia T50 50MG/ML | 30ML with dropper
LiquiClen 200MCG/ML | 30ML with dropper
Liquistane / Exemestane 25MG/ML | 30ML with dropper
LiquiTamo 20MG/ML | 30ML with dropper
LiquiVia 25MG/ML | 30 ML with dropper
T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper
Toremifene Citrate 60MG/ML | 30ML with dropper
Yohimbine HCL 10MG/ML | 30ML with dropper
Research Peptides
Aicar 50MG
BPC-157 + TB-500 Blend 2mg ea/ 4MG
BPC-157 5MG
CJC-1295 + DAC 2MG
CJC-1295 | No DAC 2MG
Epithalon 10MG
Frag Premium 176-191 5MG
GHK-CU Copper Peptide 50MG
GHRP-2 5MG
GHRP-6 5MG
Hexarelin 5MG
IGF-1 DES 1MG
IGF-1 LR3 1MG
Ipamorelin 5MG
Melanotan 2 10MG
NAD+ 500MG
PT-141 / Bremelanotide 10MG
GLP-1/GIP/GCG (RT)
Selank 5MG
GLP1 (SM)
Sermorelin 5MG
TB-500 5MG
GIP/GLP-1 (TZ)
PDE5 Inhibitors
GLP-1
Diluents
Bacteriostatic Water 10ML